HUMAN FAECAL MATTER
Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
City of Hope Medical Centerother_biologicalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Axicabtagene Ciloleucel Ruijin Hospital | Phase 4 | BBB |
Anakinra M.D. Anderson Cancer Center | Phase 2 | B |
Egfrt/19-28Z/Il-12 Car T-Lymphocytes Roswell Park Cancer Institute | Phase 1 | CC |
Same molecule, other indications
HUMAN FAECAL MATTER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →